FDA Adverse Event Injury Summary report: N

CARDIVA MEDICAL INC. VASCADE MVP VCS

MDR report key: 23521879 · Received November 11, 2025

Report

Report Number
3011469355-2025-00046
Event Type
Injury
Date Received
November 11, 2025
Date of Event
September 9, 2025
Report Date
November 11, 2025
Manufacturer
CARDIVA MEDICAL, INC.
Product Code
MGB
PMA / PMN Number
P120016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED BY THE USER FACILITY, AND NO SERIAL NUMBER WAS PROVIDED. AS A RESULT, THE DEVICE'S MANUFACTURING RECORDS CANNOT BE REVIEWED. THE CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED. INFECTION IS A KNOWN, POSSIBLE RISK WITH AN INCISION WHICH IS DISCLOSED IN THE PRODUCT IFU. THE INSTRUCTION MANUAL FOR THE VASCADE MVP STATES "WARNING DO NOT RELEASE THE COLLAGEN PATCH IF ANY PART OF THE WHITE MARKER STRIPE IS SHOWING (E.G. TISSUE TRACT IS TOO SHORT), AS THIS MAY INCREASE THE RISK OF INFECTION IF THE COLLAGEN PROTRUDES FROM THE SKIN."

Description of Event or Problem · 0

A PATIENT UNDERWENT AN ABLATION PROCEDURE UTILIZING THE VASCADE MVP CLOSURE DEVICE, WHICH WAS DEPLOYED THROUGH AN 8 FR SHEATH. NO DEVICE ANOMALIES OR COMPLICATIONS WERE REPORTED DURING THE INITIAL PROCEDURE. ONE WEEK POSTOPERATIVELY, THE PATIENT PRESENTED TO THE USER FACILITY WITH A LOCALIZED INFECTION AT THE ACCESS SITE. THE PATIENT WAS SUBSEQUENTLY PRESCRIBED ANTIBIOTICS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2525134 CARDIVA MEDICAL INC. VASCADE MVP VCS VASCADE MVP MGB CARDIVA MEDICAL, INC. 800-612C

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention